The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

A phase 3b trial showed adjuvanted RSVPreF3 vaccination was immunogenic and safe for younger adults with chronic conditions at increased risk for RSV disease.

New research suggests the skin does much more than detect damage or keep pathogens out. By tracing how skin cells respond to ...

A collaborative effort led by Professor Wanli Liu 's team at Tsinghua University has uncovered a sophisticated mechanism by which keratinocytes, the predominant cell type in the skin's epidermis, ...

Researchers developed a micro-volume assay that quantifies T-cell responses and antibodies from fingertip blood, offering a ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

With the prevalence of infectious diseases, the rapid assessment of population-specific immune protection has become important for public health. A ...

Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting engineered particles can influence immune metabolism in ways that may ...

The skin is far more than a simple physical barrier. These two researches address a fundamental question in immunology: How does a localized skin ...

An AI model that screens ionizable lipids by 3D conformation identified a candidate 14.8 times more efficient than current ...

The bispecific T-cell engager talquetamab (Talvey) has some distinct adverse events (AEs) compared with drugs of the same class that target B-cell maturation antigen (BCMA) in mul ...

Patients with RA who use abatacept mount little humoral or cell-mediated responses to the recombinant zoster vaccine, with more injection-site reactions but similar RA flare rates compared with ...